Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.
about
Exosomes From Adipose-derived Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Wnt/β-Catenin Signaling Pathway.Human Bone Marrow Mesenchymal Stem/Stromal Cells Preserve Their Immunomodulatory and Chemotactic Properties When Expanded in a Human Plasma Derived Xeno-Free Medium.Inhibitory effect of dihydroartemisinin on chondrogenic and hypertrophic differentiation of mesenchymal stem cellsRandomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.Manufacturing Cell Therapies Using Engineered Biomaterials.Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways.Vascular Diseases and Metabolic DisordersCCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.Cardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis.Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activationOmentin-1 effects on mesenchymal stem cells: proliferation, apoptosis, and angiogenesis in vitro.Neupogen and mesenchymal stem cells are the novel therapeutic agents in regeneration of induced endometrial fibrosis in experimental rats.Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy.Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine.Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis.The Optimal Intervention Time of Bone Marrow Mesenchymal Stem Cells in Ameliorating Cardiac Fibrosis Induced by Viral Myocarditis: A Randomized Controlled Trial in Mice.Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function.Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways.Engineering of cell-laden gelatin-based microgels for cell delivery and immobilization in regenerative therapies.Establishment of xenogeneic serum-free culture methods for handling human dental pulp stem cells using clinically oriented in-vitro and in-vivo conditions.Human umbilical cord mesenchymal stem cells alleviate interstitial fibrosis and cardiac dysfunction in a dilated cardiomyopathy rat model by inhibiting TNF‑α and TGF‑β1/ERK1/2 signaling pathways.New insights into cell-based therapy for heart failure from the CHART-1 study.Stem cell therapy for acute myocardial infarction: on the horizon or still a dream?Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p.Recent Progress in Stem Cell Modification for Cardiac Regeneration.Single-cell analysis of the fate of c-kit-positive bone marrow cells.Cardiac Cell Therapy 3.0: The Beginning of the End or the End of the Beginning?Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles.Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation.Mesenchymal stem cells confer resistance to doxorubicin-induced cardiac senescence by inhibiting microRNA-34a.CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Human Medium- and Large-Sized Arteries
P2860
Q30491901-AC5738E1-BBB3-41FC-9735-FAA0D617E012Q30853758-6DE43521-38B3-45A3-89A7-9ECF6D152001Q33850225-D0E55742-2460-4BFD-AC1B-9694BC1E986AQ37624397-DC9432D6-BCE5-497C-9B91-3D8237B4AF75Q38657159-D948FA34-670E-410D-817C-34AE5905363BQ39534918-497142CE-EC7C-41D1-A768-74BFDD8D12E4Q41643651-B97FF111-B1A1-43C6-9AD4-45E07FB624AAQ41919795-D6185AF9-DC54-4B8F-9985-0229CDFF7BFCQ42278077-21C1AC7E-402A-44A6-8FF9-5903D50FF899Q42371477-744FE4D3-23F4-4B71-9942-A71533704773Q42373535-520EB711-A520-4310-B3CA-EE418CB369E7Q42374358-CF6B89F9-9A0B-4280-8C74-1E963B5D66CAQ44370413-29D7AE4E-4C9D-4A4B-ACB9-6E69939E470AQ46130031-0E22781A-ED69-48A0-8A4D-73D7C23DA71EQ46404769-32565269-60E1-47CC-8502-F63D1FCE5FF2Q47549509-B6BB1D12-7900-4774-AF50-70F874A72328Q47562176-6AFD148C-C1D7-4AFD-8E64-AB4A13C08056Q47620195-2D0CC2A0-0874-4EF0-90D5-C31FF94E6FC9Q47697073-5B4217B7-97D2-4EC0-A634-A39006D082BAQ47699787-192099F6-C3C4-495E-B6E3-60F24414E2FAQ48514918-955DF910-7F6F-4243-A968-2B71AAB29D7EQ49333970-320DA923-76C7-4E92-BE20-C52AEB1753A7Q49833988-00069CBC-8691-4B36-88CA-7B27C8BA3D3FQ49997144-CECDE767-D773-4571-8063-ADFDF826247EQ50203037-DE681238-6A06-4CA5-97FC-D3D17A616575Q52577359-6EB07FD0-5A75-4779-BEF9-04E79BA6D2A7Q52657125-DEB6BF1F-B802-4D4D-B84A-7DB4BBB42B4FQ52729623-BD079F03-D3CD-47FF-A6F0-7FD94AA7921BQ54255801-DE2131F8-F04D-479E-AC84-1AB63703A5ABQ55071721-6617374A-CFE2-481C-8DBB-DACC7B6E698BQ55080659-F681B91B-2BB0-401A-AF49-27B7CB919638Q55312032-BB7B9393-E6A8-4A0C-A3FD-BB90667AB2FBQ56985593-3CAE3E78-69B8-4874-8816-E9008FA5A179
P2860
Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Rebuilding the Damaged Heart: ...... , and Engineered Heart Tissue.
@en
type
label
Rebuilding the Damaged Heart: ...... , and Engineered Heart Tissue.
@en
prefLabel
Rebuilding the Damaged Heart: ...... , and Engineered Heart Tissue.
@en
P2093
P2860
P1476
Rebuilding the Damaged Heart: ...... y, and Engineered Heart Tissue
@en
P2093
Ariel Wolf
Joshua M Hare
Konstantinos E Hatzistergos
Samuel Golpanian
P2860
P304
P356
10.1152/PHYSREV.00019.2015
P577
2016-07-01T00:00:00Z